Search Results - "Naujokas, Marisa F"

  • Showing 1 - 13 results of 13
Refine Results
  1. 1

    The broad scope of health effects from chronic arsenic exposure: update on a worldwide public health problem by Naujokas, Marisa F, Anderson, Beth, Ahsan, Habibul, Aposhian, H Vasken, Graziano, Joseph H, Thompson, Claudia, Suk, William A

    Published in Environmental health perspectives (01-03-2013)
    “…Concerns for arsenic exposure are not limited to toxic waste sites and massive poisoning events. Chronic exposure continues to be a major public health problem…”
    Get full text
    Journal Article
  2. 2

    Arsenic and Environmental Health: State of the Science and Future Research Opportunities by Carlin, Danielle J, Naujokas, Marisa F, Bradham, Karen D, Cowden, John, Heacock, Michelle, Henry, Heather F, Lee, Janice S, Thomas, David J, Thompson, Claudia, Tokar, Erik J, Waalkes, Michael P, Birnbaum, Linda S, Suk, William A

    Published in Environmental health perspectives (01-07-2016)
    “…Exposure to inorganic and organic arsenic compounds is a major public health problem that affects hundreds of millions of people worldwide. Exposure to arsenic…”
    Get full text
    Journal Article
  3. 3

    Bioavailability-Based In Situ Remediation To Meet Future Lead (Pb) Standards in Urban Soils and Gardens by Henry, Heather, Naujokas, Marisa F, Attanayake, Chammi, Basta, Nicholas T, Cheng, Zhongqi, Hettiarachchi, Ganga M, Maddaloni, Mark, Schadt, Christopher, Scheckel, Kirk G

    Published in Environmental science & technology (04-08-2015)
    “…Recently the Centers for Disease Control and Prevention lowered the blood Pb reference value to 5 μg/dL. The lower reference value combined with increased…”
    Get full text
    Journal Article
  4. 4

    Interweaving Knowledge Resources to Address Complex Environmental Health Challenges by Anderson, Beth Ellen, Naujokas, Marisa F, Suk, William A

    Published in Environmental health perspectives (01-11-2015)
    “…Complex problems do not respect academic disciplinary boundaries. Environmental health research is complex and often moves beyond these boundaries, integrating…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Proteolysis of Major Histocompatibility Complex Class II-Associated Invariant Chain is Regulated by the Alternatively Spliced Gene Product, p41 by Fineschi, Beatrice, Arneson, Lynne S., Naujokas, Marisa F., Miller, Jim

    “…Invariant chain (Ii) is an intracellular type II transmembrane glycoprotein that is associated with major histocompatibility complex class II molecules during…”
    Get full text
    Journal Article
  7. 7

    Altered cell cycle phase distributions in cultured human carcinoma cells partially depleted of polyamines by treatment with difluoromethylornithine by SEIDENFELD, J, BLOCK, A. L, KOMAR, K. A, NAUJOKAS, M. F

    Published in Cancer research (Chicago, Ill.) (1986)
    “…We have studied the effects of partial polyamine depletion, induced by treatment with alpha-difluoromethylornithine (DFMO) on cell cycle phase distributions in…”
    Get full text
    Journal Article
  8. 8

    The chondroitin sulfate form of invariant chain can enhance stimulation of T cell responses through interaction with CD44 by Naujokas, M F, Morin, M, Anderson, M S, Peterson, M, Miller, J

    Published in Cell (30-07-1993)
    “…Invariant chain (Ii) is a nonpolymorphic glycoprotein that associates with major histocompatibility complex class II molecules and has been shown to mediate…”
    Get more information
    Journal Article
  9. 9

    Potent effects of low levels of MHC class II-associated invariant chain on CD4 + T cell development by Naujokas, Marisa F., Arneson, Lynne S., Fineschi, Beatrice, Peterson, Mary E., Sitterding, Stephanie, Hammond, Adam T., Reilly, Christina, Lo, David, Miller, Jim

    Published in Immunity (Cambridge, Mass.) (01-09-1995)
    “…Invariant chain (li)-negative mice exhibit defects in MHC class II assembly and transport that results in reduced levels of surface class II, altered antigen…”
    Get full text
    Journal Article
  10. 10

    T helper subset differentiation in the absence of invariant chain by Brown, D R, Swier, K, Moskowitz, N H, Naujokas, M F, Locksley, R M, Reiner, S L

    Published in The Journal of experimental medicine (06-01-1997)
    “…The outcome of murine infection with Leishmania major is regulated by major histocompatibility complex class II-restricted T helper cells. Invariant…”
    Get full text
    Journal Article
  11. 11

    T Cell Recognition of Flanking Residues of Murine Invariant Chain-Derived CLIP Peptide Bound to MHC Class II by Naujokas, Marisa F., Southwood, Scott, Mathies, Sonya J., Appella, Ettore, Sette, Alessandro, Miller, Jim

    Published in Cellular immunology (25-08-1998)
    “…The major site of interaction between MHC class II molecules and invariant chain has been mapped to occupancy of the class II peptide-binding site by the CLIP…”
    Get full text
    Journal Article
  12. 12

    Reduced cytocidal efficacy for adriamycin in cultured human carcinoma cells depleted of polyamines by difluoromethylornithine treatment by SEIDENFELD, J, KOMAR, K. A, NAUJOKAS, M. F, BLOCK, A. L

    Published in Cancer research (Chicago, Ill.) (01-03-1986)
    “…We have studied the effect of pretreatment with difluoromethylornithine (DFMO), an ornithine decarboxylase inhibitor, on the cytocidal responses of four human…”
    Get full text
    Journal Article
  13. 13

    Effects of DFMO-induced polyamine depletion on human tumor cell sensitivity to antineoplastic DNA-crosslinking drugs by SEIDENFELD, J, KOMAR, K. A, NAUJOKAS, M. F, BLOCK, A. L

    Published in Cancer chemotherapy and pharmacology (01-05-1986)
    “…We investigated the effect of pretreatment with difluoromethylornithine (DFMO), an ornithine decarboxylase inhibitor, on the cytocidal responses of four human…”
    Get full text
    Journal Article